Global Non-Steroidal Anti-Inflammatory Drugs market size is predicted to grow from US$ 23330 million in 2025 to US$ 32280 million in 2031; it is expected to grow at a CAGR of 5.6% from 2025 to 2031.

Global Non-Steroidal Anti-Inflammatory Drugs Market Size, Share and Analysis

The global Non-Steroidal Anti-Inflammatory Drugs market size is predicted to grow from US$ 23330 million in 2025 to US$ 32280 million in 2031; it is expected to grow at a CAGR of 5.6% from 2025 to 2031. Non-Steroidal Anti-Inflammatory Drugs are members of a therapeutic drug class which reduces pain, decreases inflammation, decreases fever,[1] and prevents blood clots. Side effects depend on the specific drug, its dose and duration of use, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack, and kidney disease. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. LPI (LP Information) newest research report, the Non-Steroidal Anti-Inflammatory Drugs Industry Forecast looks at past sales and reviews total world Non-Steroidal Anti-Inflammatory Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Non-Steroidal Anti-Inflammatory Drugs sales for 2025 through 2031. With Non-Steroidal Anti-Inflammatory Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-Steroidal Anti-Inflammatory Drugs industry. This Insight Report provides a comprehensive analysis of the global Non-Steroidal Anti-Inflammatory Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Non-Steroidal Anti-Inflammatory Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Non-Steroidal Anti-Inflammatory Drugs market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-Steroidal Anti-Inflammatory Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-Steroidal Anti-Inflammatory Drugs. This report presents a comprehensive overview, market shares, and growth opportunities of Non-Steroidal Anti-Inflammatory Drugs market by product type, application, key players and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Non-Selective NSAIDs &nbsp;&nbsp;&nbsp; COX-2 Selective NSAIDs Segmentation by Application: &nbsp;&nbsp;&nbsp; Dental Pain &nbsp;&nbsp;&nbsp; Muscle Aches &nbsp;&nbsp;&nbsp; Pain caused by Gout &nbsp;&nbsp;&nbsp; Bursitis &nbsp;&nbsp;&nbsp; Menstrual Cramps &nbsp;&nbsp;&nbsp; Fever &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Pfizer Inc. &nbsp;&nbsp;&nbsp; Bayer AG &nbsp;&nbsp;&nbsp; GSK plc &nbsp;&nbsp;&nbsp; Dr. Reddys Laboratories Ltd &nbsp;&nbsp;&nbsp; Viatris Inc &nbsp;&nbsp;&nbsp; Teva Pharmaceutical Industries Ltd. &nbsp;&nbsp;&nbsp; Johnson And Johnson Services, Inc. &nbsp;&nbsp;&nbsp; Merck & Co., Inc.

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Non-Steroidal Anti-Inflammatory Drugs Market Size (2020-2031) &nbsp;2.1.2 Non-Steroidal Anti-Inflammatory Drugs Market Size CAGR by Region (2020 VS 2024 VS 2031) &nbsp;2.1.3 World Current & Future Analysis for Non-Steroidal Anti-Inflammatory Drugs by Country/Region (2020, 2024 & 2031) &nbsp;2.2 Non-Steroidal Anti-Inflammatory Drugs Segment by Type &nbsp;2.2.1 Non-Selective NSAIDs &nbsp;2.2.2 COX-2 Selective NSAIDs &nbsp;2.3 Non-Steroidal Anti-Inflammatory Drugs Market Size by Type &nbsp;2.3.1 Non-Steroidal Anti-Inflammatory Drugs Market Size CAGR by Type (2020 VS 2024 VS 2031) &nbsp;2.3.2 Global Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Type (2020-2025) &nbsp;2.4 Non-Steroidal Anti-Inflammatory Drugs Segment by Application &nbsp;2.4.1 Dental Pain &nbsp;2.4.2 Muscle Aches &nbsp;2.4.3 Pain caused by Gout &nbsp;2.4.4 Bursitis &nbsp;2.4.5 Menstrual Cramps &nbsp;2.4.6 Fever &nbsp;2.4.7 Others &nbsp;2.5 Non-Steroidal Anti-Inflammatory Drugs Market Size by Application &nbsp;2.5.1 Non-Steroidal Anti-Inflammatory Drugs Market Size CAGR by Application (2020 VS 2024 VS 2031) &nbsp;2.5.2 Global Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Application (2020-2025) 3 Non-Steroidal Anti-Inflammatory Drugs Market Size by Player &nbsp;3.1 Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Player &nbsp;3.1.1 Global Non-Steroidal Anti-Inflammatory Drugs Revenue by Player (2020-2025) &nbsp;3.1.2 Global Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Player (2020-2025) &nbsp;3.2 Global Non-Steroidal Anti-Inflammatory Drugs Key Players Head office and Products Offered &nbsp;3.3 Market Concentration Rate Analysis &nbsp;3.3.1 Competition Landscape Analysis &nbsp;3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.4 New Products and Potential Entrants &nbsp;3.5 Mergers & Acquisitions, Expansion 4 Non-Steroidal Anti-Inflammatory Drugs by Region &nbsp;4.1 Non-Steroidal Anti-Inflammatory Drugs Market Size by Region (2020-2025) &nbsp;4.2 Global Non-Steroidal Anti-Inflammatory Drugs Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Non-Steroidal Anti-Inflammatory Drugs Market Size Growth (2020-2025) &nbsp;4.4 APAC Non-Steroidal Anti-Inflammatory Drugs Market Size Growth (2020-2025) &nbsp;4.5 Europe Non-Steroidal Anti-Inflammatory Drugs Market Size Growth (2020-2025) &nbsp;4.6 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Market Size Growth (2020-2025) 5 Americas &nbsp;5.1 Americas Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2020-2025) &nbsp;5.2 Americas Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2020-2025) &nbsp;5.3 Americas Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Non-Steroidal Anti-Inflammatory Drugs Market Size by Region (2020-2025) &nbsp;6.2 APAC Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2020-2025) &nbsp;6.3 APAC Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia 7 Europe &nbsp;7.1 Europe Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2020-2025) &nbsp;7.2 Europe Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2020-2025) &nbsp;7.3 Europe Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs by Region (2020-2025) &nbsp;8.2 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2020-2025) &nbsp;8.3 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Global Non-Steroidal Anti-Inflammatory Drugs Market Forecast &nbsp;10.1 Global Non-Steroidal Anti-Inflammatory Drugs Forecast by Region (2026-2031) &nbsp;10.1.1 Global Non-Steroidal Anti-Inflammatory Drugs Forecast by Region (2026-2031) &nbsp;10.1.2 Americas Non-Steroidal Anti-Inflammatory Drugs Forecast &nbsp;10.1.3 APAC Non-Steroidal Anti-Inflammatory Drugs Forecast &nbsp;10.1.4 Europe Non-Steroidal Anti-Inflammatory Drugs Forecast &nbsp;10.1.5 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Forecast &nbsp;10.2 Americas Non-Steroidal Anti-Inflammatory Drugs Forecast by Country (2026-2031) &nbsp;10.2.1 United States Market Non-Steroidal Anti-Inflammatory Drugs Forecast &nbsp;10.2.2 Canada Market Non-Steroidal Anti-Inflammatory Drugs Forecast &nbsp;10.2.3 Mexico Market Non-Steroidal Anti-Inflammatory Drugs Forecast &nbsp;10.2.4 Brazil Market Non-Steroidal Anti-Inflammatory Drugs Forecast &nbsp;10.3 APAC Non-Steroidal Anti-Inflammatory Drugs Forecast by Region (2026-2031) &nbsp;10.3.1 China Non-Steroidal Anti-Inflammatory Drugs Market Forecast &nbsp;10.3.2 Japan Market Non-Steroidal Anti-Inflammatory Drugs Forecast &nbsp;10.3.3 Korea Market Non-Steroidal Anti-Inflammatory Drugs Forecast &nbsp;10.3.4 Southeast Asia Market Non-Steroidal Anti-Inflammatory Drugs Forecast &nbsp;10.3.5 India Market Non-Steroidal Anti-Inflammatory Drugs Forecast &nbsp;10.3.6 Australia Market Non-Steroidal Anti-Inflammatory Drugs Forecast &nbsp;10.4 Europe Non-Steroidal Anti-Inflammatory Drugs Forecast by Country (2026-2031) &nbsp;10.4.1 Germany Market Non-Steroidal Anti-Inflammatory Drugs Forecast &nbsp;10.4.2 France Market Non-Steroidal Anti-Inflammatory Drugs Forecast &nbsp;10.4.3 UK Market Non-Steroidal Anti-Inflammatory Drugs Forecast &nbsp;10.4.4 Italy Market Non-Steroidal Anti-Inflammatory Drugs Forecast &nbsp;10.4.5 Russia Market Non-Steroidal Anti-Inflammatory Drugs Forecast &nbsp;10.5 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Forecast by Region (2026-2031) &nbsp;10.5.1 Egypt Market Non-Steroidal Anti-Inflammatory Drugs Forecast &nbsp;10.5.2 South Africa Market Non-Steroidal Anti-Inflammatory Drugs Forecast &nbsp;10.5.3 Israel Market Non-Steroidal Anti-Inflammatory Drugs Forecast &nbsp;10.5.4 Turkey Market Non-Steroidal Anti-Inflammatory Drugs Forecast &nbsp;10.6 Global Non-Steroidal Anti-Inflammatory Drugs Forecast by Type (2026-2031) &nbsp;10.7 Global Non-Steroidal Anti-Inflammatory Drugs Forecast by Application (2026-2031) &nbsp;10.7.1 GCC Countries Market Non-Steroidal Anti-Inflammatory Drugs Forecast 11 Key Players Analysis &nbsp;11.1 Pfizer Inc. &nbsp;11.1.1 Pfizer Inc. Company Information &nbsp;11.1.2 Pfizer Inc. Non-Steroidal Anti-Inflammatory Drugs Product Offered &nbsp;11.1.3 Pfizer Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.1.4 Pfizer Inc. Main Business Overview &nbsp;11.1.5 Pfizer Inc. Latest Developments &nbsp;11.2 Bayer AG &nbsp;11.2.1 Bayer AG Company Information &nbsp;11.2.2 Bayer AG Non-Steroidal Anti-Inflammatory Drugs Product Offered &nbsp;11.2.3 Bayer AG Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.2.4 Bayer AG Main Business Overview &nbsp;11.2.5 Bayer AG Latest Developments &nbsp;11.3 GSK plc &nbsp;11.3.1 GSK plc Company Information &nbsp;11.3.2 GSK plc Non-Steroidal Anti-Inflammatory Drugs Product Offered &nbsp;11.3.3 GSK plc Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.3.4 GSK plc Main Business Overview &nbsp;11.3.5 GSK plc Latest Developments &nbsp;11.4 Dr. Reddy�s Laboratories Ltd &nbsp;11.4.1 Dr. Reddy�s Laboratories Ltd Company Information &nbsp;11.4.2 Dr. Reddy�s Laboratories Ltd Non-Steroidal Anti-Inflammatory Drugs Product Offered &nbsp;11.4.3 Dr. Reddy�s Laboratories Ltd Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.4.4 Dr. Reddy�s Laboratories Ltd Main Business Overview &nbsp;11.4.5 Dr. Reddy�s Laboratories Ltd Latest Developments &nbsp;11.5 Viatris Inc &nbsp;11.5.1 Viatris Inc Company Information &nbsp;11.5.2 Viatris Inc Non-Steroidal Anti-Inflammatory Drugs Product Offered &nbsp;11.5.3 Viatris Inc Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.5.4 Viatris Inc Main Business Overview &nbsp;11.5.5 Viatris Inc Latest Developments &nbsp;11.6 Teva Pharmaceutical Industries Ltd. &nbsp;11.6.1 Teva Pharmaceutical Industries Ltd. Company Information &nbsp;11.6.2 Teva Pharmaceutical Industries Ltd. Non-Steroidal Anti-Inflammatory Drugs Product Offered &nbsp;11.6.3 Teva Pharmaceutical Industries Ltd. Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.6.4 Teva Pharmaceutical Industries Ltd. Main Business Overview &nbsp;11.6.5 Teva Pharmaceutical Industries Ltd. Latest Developments &nbsp;11.7 Johnson And Johnson Services, Inc. &nbsp;11.7.1 Johnson And Johnson Services, Inc. Company Information &nbsp;11.7.2 Johnson And Johnson Services, Inc. Non-Steroidal Anti-Inflammatory Drugs Product Offered &nbsp;11.7.3 Johnson And Johnson Services, Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.7.4 Johnson And Johnson Services, Inc. Main Business Overview &nbsp;11.7.5 Johnson And Johnson Services, Inc. Latest Developments &nbsp;11.8 Merck & Co., Inc. &nbsp;11.8.1 Merck & Co., Inc. Company Information &nbsp;11.8.2 Merck & Co., Inc. Non-Steroidal Anti-Inflammatory Drugs Product Offered &nbsp;11.8.3 Merck & Co., Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.8.4 Merck & Co., Inc. Main Business Overview &nbsp;11.8.5 Merck & Co., Inc. Latest Developments 12 Research Findings and Conclusion

Report	Global Non-Steroidal Anti-Inflammatory Drugs Market Growth, Trends and Opportunities 2025-31
Selected License	Multi ID: LPI50492

Buyer Information

Order Summary